A Message from the Director
Eight Years of Progress
Here at the Taubman Institute, we are building on the momentum of eight productive and exciting years.
We currently are funding seven Senior Taubman Scholars, seven Taubman Scholars and 18 Emerging Scholars, who with our and your support are doing groundbreaking research that will have profound effects on the understanding and treatment of a range of diseases.
We also are working to create the collaborative environment that is one of the cornerstones of the Institute, where the exchange of ideas and creative interaction across disciplines are vigorously promoted.
We also hold brown-bag lunches -- where members of all the Taubman labs get together to discuss their research – and the scholars regularly gather for “chalk talks” to share, discuss and debate their findings.
Throughout the coming months, I invite your continued interest in the work of the Taubman Institute. To keep up with our research and news from the laboratories, please bookmark our website at www.taubmaninsitute.org.
This is a very exciting era in the search for treatments of some of the most devastating illnesses that strike individuals and families. With the commitment of our scientists and the sustained support of people like Alfred Taubman, we are moving forward in our quest to challenge head-on some of today’s most deadly diseases.
Eva Feldman, M.D., Ph.D., F.A.A.N., F.A.N.A.
Director, Taubman Medical Research Institute
Professor of Neurology, University of Michigan Medical School
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars Symposium set for April 29
Annual showcase of early career physician-researchers runs 10 a.m. to noon at the A. Alfred Taubman Biomedical Science Research Building.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results